Kilter Group’s Veracyte VCYT Stock Holding History

Kilter Group’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.52K	Hold	94	–	–	﹤0.01%	644
2026 Q1	$3.03K	Buy	+94	New	+$3.48K	﹤0.01%	781

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Kilter Group's VCYT Position: Q2 2026 in Review

Kilter Group held its Veracyte (VCYT) position steady in Q2 2026 at 94 shares worth $5.52K. The position accounts for ﹤0.01% of the portfolio, ranked #644.

Kilter Group first reported a position in VCYT in Q1 2026 and has held it in 2 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Kilter Group held 94 shares of Veracyte worth $5.52K as of Q2 2026.
Kilter Group left its Veracyte share count unchanged in Q2 2026.
Veracyte made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #644 holding.
Kilter Group first reported a position in Veracyte in Q1 2026 and has held it in 2 quarters since.
370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.